NCT03665428View on ClinicalTrials.gov

Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea

PHASE4CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

August 6, 2019

Study Completion Date

December 31, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

PAMB treatment (modified quadruple therapy)

Randomly assign either as PAMB or PBMT group treatment

DRUG

PBMT treatment (bismuth-containing quadruple therapy)

Randomly assign either as PAMB or PBMT group treatment

Trial Locations (1)

24253

Chuncheon Sacred Heart hospital, Chuncheon

All Listed Sponsors
collaborator

Hallym University Medical Center

OTHER

lead

Chuncheon Sacred Heart Hospital

OTHER

NCT03665428 - Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea | Biotech Hunter | Biotech Hunter